IL100097A0 - Pyridyl derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

Pyridyl derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL100097A0
IL100097A0 IL100097A IL10009791A IL100097A0 IL 100097 A0 IL100097 A0 IL 100097A0 IL 100097 A IL100097 A IL 100097A IL 10009791 A IL10009791 A IL 10009791A IL 100097 A0 IL100097 A0 IL 100097A0
Authority
IL
Israel
Prior art keywords
thromboxane
addition
preparation
pyridyl derivatives
pharmaceutical compositions
Prior art date
Application number
IL100097A
Other versions
IL100097A (en
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of IL100097A0 publication Critical patent/IL100097A0/en
Publication of IL100097A publication Critical patent/IL100097A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paper (AREA)

Abstract

The present invention relates to novel pyridyl derivatives of the general formula <IMAGE> in which R1 to R6, A, X and n are as defined in Claim 1, their enantiomers, their cis- and trans-isomers if R4 and R5 together represent a carbon-carbon bond, and their addition salts, for pharmaceutical use, in particular, their physiologically tolerable addition salts with inorganic or organic bases, if R6 represents a hydroxyl group, which have useful pharmacological properties, in particular antithrombotic effects and effects mediated by thromboxane. In addition, the novel compounds are at the same time thromboxane antagonists (TRA) and thromboxane synthesis inhibitors (TSH). In addition, they also have an effect on PGE2 production.
IL10009791A 1990-11-22 1991-11-20 Pyridyl derivatives, their preparation and pharmaceutical compositions containing them IL100097A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4037112A DE4037112A1 (en) 1990-11-22 1990-11-22 NEW PYRIDYL DERIVATIVES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF

Publications (2)

Publication Number Publication Date
IL100097A0 true IL100097A0 (en) 1992-08-18
IL100097A IL100097A (en) 1995-07-31

Family

ID=6418696

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10009791A IL100097A (en) 1990-11-22 1991-11-20 Pyridyl derivatives, their preparation and pharmaceutical compositions containing them

Country Status (19)

Country Link
EP (1) EP0487095B1 (en)
JP (1) JPH04275273A (en)
KR (1) KR920009799A (en)
AT (1) ATE134619T1 (en)
AU (1) AU640063B2 (en)
CA (1) CA2055950A1 (en)
DE (2) DE4037112A1 (en)
DK (1) DK0487095T3 (en)
ES (1) ES2084756T3 (en)
FI (1) FI915484A (en)
GR (1) GR3019783T3 (en)
HU (1) HU213676B (en)
IE (1) IE74248B1 (en)
IL (1) IL100097A (en)
NO (1) NO175634C (en)
NZ (1) NZ240677A (en)
PT (1) PT99571B (en)
RU (1) RU2028292C1 (en)
ZA (1) ZA919205B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4216364A1 (en) * 1991-12-14 1993-11-25 Thomae Gmbh Dr K Pyridyl derivs. with antithrombotic properties
TWI290549B (en) * 2000-06-02 2007-12-01 Astrazeneca Ab Process for the preparation of cyclopropyl carboxylic acid ester and derivatives
DE10225635C1 (en) * 2002-06-07 2003-12-24 Aventis Pharma Gmbh N-benzoylureido-cinnamic acid derivatives, process for their preparation and their use
FI20055498A0 (en) * 2005-09-16 2005-09-16 Biotie Therapies Corp Sulfonamides
EP2928860A1 (en) * 2012-12-10 2015-10-14 H. Lundbeck A/S New positive allosteric modulators of nicotinic acetylcholine receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518602A (en) * 1982-10-07 1985-05-21 Takeda Chemical Industries, Ltd. Vinyl carboxylic acid derivatives, their production and use as inhibitors of thromboxane synthetase
GB8708233D0 (en) * 1987-04-07 1987-05-13 Smith Kline French Lab Pharmaceutically active compounds
DE3932403A1 (en) * 1989-05-12 1991-04-11 Thomae Gmbh Dr K NEW ARYLSULFONAMIDES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
IE74248B1 (en) 1997-07-16
ES2084756T3 (en) 1996-05-16
KR920009799A (en) 1992-06-25
PT99571B (en) 1999-04-30
GR3019783T3 (en) 1996-07-31
HU213676B (en) 1997-09-29
RU2028292C1 (en) 1995-02-09
EP0487095A1 (en) 1992-05-27
NO175634C (en) 1994-11-09
HU913644D0 (en) 1992-02-28
HUT60472A (en) 1992-09-28
NO914567D0 (en) 1991-11-21
DE4037112A1 (en) 1992-05-27
ZA919205B (en) 1993-05-21
IE914048A1 (en) 1992-06-03
DK0487095T3 (en) 1996-06-24
AU8796491A (en) 1992-05-28
ATE134619T1 (en) 1996-03-15
NO175634B (en) 1994-08-01
NO914567L (en) 1992-05-25
IL100097A (en) 1995-07-31
AU640063B2 (en) 1993-08-12
JPH04275273A (en) 1992-09-30
NZ240677A (en) 1994-12-22
FI915484A0 (en) 1991-11-21
FI915484A (en) 1992-05-23
DE59107462D1 (en) 1996-04-04
PT99571A (en) 1992-10-30
CA2055950A1 (en) 1992-05-23
EP0487095B1 (en) 1996-02-28

Similar Documents

Publication Publication Date Title
CA2067877A1 (en) Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present
IL94347A0 (en) Arylsulphonamides,their preparation and pharmaceutical compositions containing them
DE59202241D1 (en) New pyridyl derivatives, pharmaceutical compositions containing these compounds and process for their preparation.
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
IL100097A0 (en) Pyridyl derivatives,their preparation and pharmaceutical compositions containing them
EP0189916A3 (en) 3-(pyrrolidinio)methyl-3-cephem derivatives, pharmaceutical composition and process for the production thereof
ATE100102T1 (en) SUBSTITUTED DERIVATIVES OF 20,21DINOREBUNAMENINE, PROCESSES FOR THE MANUFACTURE AND INTERMEDIATE PRODUCTS SO MANUFACTURED, THEIR USE AS MEDICINAL PRODUCTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2655042B1 (en) NOVEL SUBSTITUTED BENZOTHIAZOLINONES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES464773A1 (en) 2,9-Dioxatricyclo{8 4,3,1,0{hu 3,7{b {9 decane derivatives, processes for their preparation and pharmaceutical compositions thereof
CA2217479A1 (en) Derivatives of phenoxyethylamine having a high affinity for 5-ht1a receptor, their preparation procedure, their application as medications and pharmaceutical compounds containing them
HUT59399A (en) Process for producing substituted 3-aminosydnone imine derivatives and pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees